By Professor Caroline Ford

Conference Papers

Werner B; Powell E; Duggan J; Lee YC; Athavale R; Dean M; Warton K; Ford C, 2023, 'PR004/#458  Cell-free DNA from ascites identifies clinically relevant variants and tumour evolution in a cohort of patients with advanced ovarian cancer', in Featured Posters: Poster Rounds with the Professors, BMJ Publishing Group Ltd, presented at IGCS 2023 Annual Meeting Abstracts, http://dx.doi.org/10.1136/ijgc-2023-igcs.47

Xu X; Wang Y; Bryce N; Tang K; Meagher NS; Kang EY; Kelemen LE; Köbel M; Ramus SJ; Friedlander M; Ford CE; Hardeman EC; Gunning PW, 2021, 'Abstract 1045: Combined targeting of actin/tropomyosin and microtubules underlies a potential treatment strategy of epithelial ovarian cancer with cell-cycle dependent synergy', in Cancer Research, American Association for Cancer Research (AACR), pp. 1045 - 1045, http://dx.doi.org/10.1158/1538-7445.am2021-1045

Liu D; Kaufmann GF; Breitmeyer JB; Dickson K-A; Marsh DJ; Ford CE, 2021, 'Abstract 1062: Inhibition of ovarian and endometrial cancer cell proliferation by an anti-ROR1 monoclonal antibody', in Cancer Research, American Association for Cancer Research (AACR), pp. 1062 - 1062, http://dx.doi.org/10.1158/1538-7445.am2021-1062

Xu X; Wang Y; Bryce N; Tang K; Meagher NS; Kang EY; Kelemen LE; Kobel M; Ramus SJ; Friedlander M; Ford CE; Hardeman EC; Gunning PW, 2021, 'Combined targeting of actin/tropomyosin and microtubules underlies a potential treatment strategy of epithelial ovarian cancer with cell-cycle dependent synergy.', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000680263503257&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Liu D; Kaufmann GF; Breitmeyer JB; Dickson K-A; Marsh DJ; Ford CE, 2021, 'Inhibition of ovarian and endometrial cancer cell proliferation by an anti-ROR1 monoclonal antibody.', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000680263503274&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Liu D; Enriquez L; Daniels B; O'Mara T; Tang K; Ford C, 2021, 'Abstract PO042: ROR2 is epigenetically regulated in endometrial cancer', in Clinical Cancer Research, American Association for Cancer Research (AACR), pp. PO042 - PO042, http://dx.doi.org/10.1158/1557-3265.endomet20-po042

Liu D; John M; Henry CE; Christie EL; Bowtell DDL; Tang K; Heinzelmann-Schwarz V; Kennedy C; Boros J; DeFazio A; Ford CE, 2020, 'Abstract A41: ROR1 is associated with ovarian cancer progression and chemoresistance', in Clinical Cancer Research, American Association for Cancer Research (AACR), pp. A41 - A41, http://dx.doi.org/10.1158/1557-3265.ovca19-a41

Warton K; Yuwono N; Henry C; Hacker N; Ford C, 2020, 'Abstract B28: Optimizing DNA processing and ovarian cancer methylation-specific PCR assays for the detection of early-stage ovarian cancer', in Clinical Cancer Research, American Association for Cancer Research (AACR), pp. B28 - B28, http://dx.doi.org/10.1158/1557-3265.ovca19-b28

Warton K; Yuwono N; Henry C; Hacker N; Ford C, 2019, 'Optimizing DNA processing and ovarian cancer methylation-specific PCR assays for the detection of early-stage ovarian cancer.', in CLINICAL CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, GA, Atlanta, pp. 93 - 93, presented at AACR Special Conference on Advances in Ovarian Cancer Research, GA, Atlanta, 13 September 2019 - 16 September 2019, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000546013300143&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Henry CE; Hacker NF; Ford CE, 2018, 'Shock and ROR! Targeting ROR1 and ROR2 in a preclinical patient-derived model of ovarian cancer', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, IL, Chicago, presented at Annual Meeting of the American-Association-for-Cancer-Research (AACR), IL, Chicago, 14 April 2018 - 18 April 2018, http://dx.doi.org/10.1158/1538-7445.AM2018-106

Henry CE; Llamosas E; Hacker NF; Heinzelmann-Schwarz V; Ford CE, 2016, 'The role of the ROR receptors in ovarian cancer progression and chemoresistance', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, LA, New Orleans, presented at 107th Annual Meeting of the American-Association-of-Cancer-Research (AACR), LA, New Orleans, 16 April 2016 - 20 April 2016, http://dx.doi.org/10.1158/1538-7445.AM2016-1636

Ford CE; Tuomela J; Hedditch EL; Axelsson L; Liu Q; Ward RL; Harkonen P; Andersson T, 2010, 'Estrogen receptor alpha is upregulated and metastasis inhibited in a murine breast cancer model following treatment with the novel Wnt-5a derived-hexapeptide, Foxy-5', in EJC SUPPLEMENTS, PERGAMON-ELSEVIER SCIENCE LTD, NORWAY, Oslo, pp. 11 - 11, presented at 21st Meeting of the European-Association-for-Cancer-Research, NORWAY, Oslo, 26 June 2010 - 29 June 2010, http://dx.doi.org/10.1016/S1359-6349(10)70852-1

Kennedy S; Waliuzzaman Z; Ford C; Rawlinson W; Pussell B, 2005, 'Recurrent HUS following kidney transplant possibly precipitated by CMV', in IMMUNOLOGY AND CELL BIOLOGY, BLACKWELL PUBLISHING, AUSTRALIA, Canberra, pp. A16 - A17, presented at 23rd Annual Scientific Meeting of the Transplantation-Society-of-Australia-and-New-Zealand, AUSTRALIA, Canberra, 11 May 2005 - 13 May 2005, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000230636500066&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Back to profile page